Egfr Mutation Testing
EGFR Mutation Testing is a molecular diagnostic assay that identifies specific genetic alterations in the epidermal growth factor receptor (EGFR) gene within cytologic specimens to guide targeted therapy in oncology.
3.4K
Publications
235.1K
Citations
20.7K
Authors
3.9K
Institutions
Publications per year
2017–2026
1.5K
Parents
3.4K
Rafael Rosell, Enric Carcereny, Radj Gervais et al. · The Lancet Oncology · 2012 · 5.5K citations · Full text
Medicine, Oncology, Pharmacology +12
Yi‐Long Wu, Caicun Zhou, Chengping Hu et al. · The Lancet Oncology · 2014 · 2K citations
Medicine, Oncology, Pharmacology +11
1–5 of 3.4K
20.7K
46
h-index
39
h-index
38
h-index
38
h-index
35
h-index
1–5 of 20.7K
3.9K
Memorial Sloan Kettering Cancer Center
New York, United States
55 h-index
582 publications
112.7K citations
National Taiwan University Hospital
Taipei, Taiwan
54 h-index
395 publications
41K citations
Dana-Farber Cancer Institute
Boston, United States
54 h-index
403 publications
86.2K citations
Massachusetts General Hospital
Boston, United States
51 h-index
410 publications
181.7K citations
Harvard University
Cambridge, United States
48 h-index
349 publications
157.5K citations
Guangdong Academy of Medical Sciences
Guangzhou, China
46 h-index
330 publications
45.3K citations

Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
46 h-index
639 publications
99.9K citations
Samsung Medical Center
Seoul, South Korea
46 h-index
430 publications
30K citations
1–8 of 3.9K
206 publications · 20.1K citations
78
h-index
197 publications · 29.6K citations
70
h-index
238 publications · 12.4K citations
64
h-index
87 publications · 15.5K citations
62
h-index
106 publications · 10.2K citations
49
h-index
1–5